Eugene P. Kennedy
2018
In 2018, Eugene P. Kennedy earned a total compensation of $1.2M as Chief Medical Officer at NewLink Genetics, a 5% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $170,000 |
---|---|
Option Awards | $589,073 |
Salary | $425,000 |
Other | $24,640 |
Total | $1,208,713 |
Kennedy received $589.1K in option awards, accounting for 49% of the total pay in 2018.
Kennedy also received $170K in non-equity incentive plan, $425K in salary and $24.6K in other compensation.
Rankings
In 2018, Eugene P. Kennedy's compensation ranked 8,255th out of 14,244 executives tracked by ExecPay. In other words, Kennedy earned more than 42.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 8,255 out of 14,244 | 42nd |
Division Manufacturing | 3,265 out of 5,765 | 43rd |
Major group Chemicals And Allied Products | 1,223 out of 2,128 | 43rd |
Industry group Drugs | 1,023 out of 1,817 | 44th |
Industry Pharmaceutical Preparations | 796 out of 1,391 | 43rd |
Source: SEC filing on April 5, 2019.
Kennedy's colleagues
We found two more compensation records of executives who worked with Eugene P. Kennedy at NewLink Genetics in 2018.
News
NewLink Genetics CEO Richard Hawkins' 2020 pay jumps 200% to $2.2M
April 6, 2021
NewLink Genetics Former Chief Executive & Scientific Officer Charles Link's 2019 pay falls 38% to $1.7M
June 23, 2020
NewLink Genetics Chief Executive & Scientific Officer Charles Link's 2018 pay slips 18% to $2.8M
April 5, 2019